Literature DB >> 34309564

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation.

András Lánczky1,2, Balázs Győrffy1,2.   

Abstract

BACKGROUND: Survival analysis is a cornerstone of medical research, enabling the assessment of clinical outcomes for disease progression and treatment efficiency. Despite its central importance, no commonly used spreadsheet software can handle survival analysis and there is no web server available for its computation.
OBJECTIVE: Here, we introduce a web-based tool capable of performing univariate and multivariate Cox proportional hazards survival analysis using data generated by genomic, transcriptomic, proteomic, or metabolomic studies.
METHODS: We implemented different methods to establish cut-off values for the trichotomization or dichotomization of continuous data. The false discovery rate is computed to correct for multiple hypothesis testing. A multivariate analysis option enables comparing omics data with clinical variables.
RESULTS: We established a registration-free web-based survival analysis tool capable of performing univariate and multivariate survival analysis using any custom-generated data.
CONCLUSIONS: This tool fills a gap and will be an invaluable contribution to basic medical and clinical research. ©András Lánczky, Balázs Győrffy. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 26.07.2021.

Entities:  

Keywords:  Cox regression; Kaplan-Meier plot; follow-up; internet; multivariate analysis; survival

Year:  2021        PMID: 34309564     DOI: 10.2196/27633

Source DB:  PubMed          Journal:  J Med Internet Res        ISSN: 1438-8871            Impact factor:   5.428


  150 in total

1.  Prognostic value of tumor mutation burden and the relationship between tumor mutation burden and immune infiltration in HER2+ breast cancer: a gene expression-based study.

Authors:  Ying Wen; Dengjie Ouyang; Qitong Chen; Liyun Zeng; Na Luo; Hongye He; Munawar Anwar; Limeng Qu; Qiongyan Zou; Wenjun Yi
Journal:  Gland Surg       Date:  2022-01

2.  Genome-wide CRISPR knockout screening identified G protein pathway suppressor 2 as a novel tumor suppressor for uveal melanoma metastasis.

Authors:  Shuangshuang Shi; Haojie Chen; Hanqing Wang; JianFeng Wan; Yi Shi; Jia Li; Shuo Wang; Jie Shi; Jianying Lv; Tong Wu; Longlong Wang; Fengyuan Sun
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-08       Impact factor: 4.322

3.  ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells.

Authors:  Ofer Regev; Marina Kizner; Francesco Roncato; Maya Dadiani; Massimo Saini; Francesc Castro-Giner; Olga Yajuk; Stav Kozlovski; Nehora Levi; Yoseph Addadi; Ofra Golani; Shifra Ben-Dor; Zvi Granot; Nicola Aceto; Ronen Alon
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

4.  CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer.

Authors:  Chih-Yi Lin; Chung-Jen Yu; Chun-Yu Liu; Ta-Chung Chao; Chi-Cheng Huang; Ling-Ming Tseng; Jiun-I Lai
Journal:  Clin Transl Oncol       Date:  2022-08-02       Impact factor: 3.340

5.  Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer.

Authors:  Daniela Criscuolo; Rosario Avolio; Matteo Parri; Simona Romano; Paola Chiarugi; Danilo Swann Matassa; Franca Esposito
Journal:  Antioxidants (Basel)       Date:  2022-08-10

Review 6.  Potential Role of miR-196a and miR-196b as Prognostic Biomarkers of Survival in Head and Neck Squamous Cell Carcinoma: A Systematic Review, Meta-Analysis and Trial Sequential Analysis.

Authors:  Mario Dioguardi; Stefania Cantore; Diego Sovereto; Lucia La Femina; Giorgia Apollonia Caloro; Francesca Spirito; Salvatore Scacco; Michele Di Cosola; Lorenzo Lo Muzio; Giuseppe Troiano; Andrea Ballini
Journal:  Life (Basel)       Date:  2022-08-19

7.  Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer.

Authors:  Alison Harrod; Chun-Fui Lai; Isabella Goldsbrough; Georgia M Simmons; Natasha Oppermans; Daniela B Santos; Balazs Győrffy; Rebecca C Allsopp; Bradley J Toghill; Kirsty Balachandran; Mandy Lawson; Christopher J Morrow; Manasa Surakala; Larissa S Carnevalli; Pei Zhang; David S Guttery; Jacqueline A Shaw; R Charles Coombes; Lakjaya Buluwela; Simak Ali
Journal:  Oncogene       Date:  2022-10-05       Impact factor: 8.756

8.  Machine learning-assisted elucidation of CD81-CD44 interactions in promoting cancer stemness and extracellular vesicle integrity.

Authors:  Tujin Shi; Yang Shen; Nurmaa K Dashzeveg; Huiping Liu; Erika K Ramos; Chia-Feng Tsai; Yuzhi Jia; Yue Cao; Megan Manu; Rokana Taftaf; Andrew D Hoffmann; Lamiaa El-Shennawy; Marina A Gritsenko; Valery Adorno-Cruz; Emma J Schuster; David Scholten; Dhwani Patel; Xia Liu; Priyam Patel; Brian Wray; Youbin Zhang; Shanshan Zhang; Ronald J Moore; Jeremy V Mathews; Matthew J Schipma; Tao Liu; Valerie L Tokars; Massimo Cristofanilli
Journal:  Elife       Date:  2022-10-04       Impact factor: 8.713

9.  Cuproptosis-related gene SLC31A1 is a potential predictor for diagnosis, prognosis and therapeutic response of breast cancer.

Authors:  Xiao Li; Zhaosheng Ma; Linhang Mei
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

10.  Arctigenin impairs UBC12 enzyme activity and cullin neddylation to attenuate cancer cells.

Authors:  Yi-Fan Chen; Run-Zhi Liu; Wen-Wen Ying; Yue-Ning Yang; Sen-Feng Xiang; Xue-Jing Shao; Ji Cao; Yan-Qi Zhang; Bo Yang; Qiao-Jun He; Mei-Dan Ying
Journal:  Acta Pharmacol Sin       Date:  2022-09-22       Impact factor: 7.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.